What Is the KURE ETF? Returns, Expense Ratio, Holdings, and Alternative ETFs at a Glance
The KraneShares MSCI All China Healthcare ETF (KURE) invests in Chinese healthcare companies listed on the mainland, in Hong Kong, and in the US. It is a useful reference for Korean investors who want to weigh the growth outlook of the pharmaceutical and biotech sectors alongside an annual dividend.
SubscribeWhat Is the KraneShares MSCI All China Healthcare ETF?
This sector ETF tracks the MSCI China All Shares Healthcare index and diversifies across Chinese pharmaceutical, biotech, and medical companies. Its defining feature is a broad scope that covers mainland A-shares, Hong Kong-listed shares, and US-listed shares.
It suits investors who want to bet on the long-term growth of China's healthcare industry while reducing single-stock risk.
It is a passive (index-tracking) ETF managed by KraneShares.
How Does the KraneShares MSCI All China Healthcare ETF Invest?
| Item | Details |
|---|---|
| Tracking index | MSCI China All Shares Healthcare 10/40 |
| Management style | Passive (index tracking) |
| Rebalancing frequency | Conducted regularly according to the index methodology |
| Dividend frequency | Annual |
| Issuer | KraneShares |
| Expense ratio | 0.65% |
The fund holds the Chinese healthcare companies in the index in proportion to their market capitalization, tracking the performance of the sector as a whole. It applies a methodology that limits concentration in individual stocks, easing the skew toward top holdings, and it broadens access by holding both mainland and offshore-listed shares.
- Broad inclusion of Chinese healthcare stocks listed on the mainland, in Hong Kong, and in the US
- Concentrated exposure to a single sector makes the theme easy to understand
KraneShares MSCI All China Healthcare ETF Size and Costs (AUM and Management Fee)
Assets under management (AUM) stand at $108.5M, and the expense ratio is 0.65% per year.
Unlike KWEB and CQQQ, which are also China-themed but focus on internet and technology, this ETF offers exposure to healthcare, a sector with defensive characteristics.
KraneShares MSCI All China Healthcare ETF Performance and Trends
1-Year Price Performance
Dividend & Yield
52-Week Price RangeThe Chinese healthcare industry has shown volatility depending on policy direction, new drug development results, and the external environment. Given the nature of the sector, clinical and regulatory issues at individual companies tend to be strongly reflected in the index's movements.
Sentiment in the mainland Chinese market, the yuan's movements, and changes in US-China relations all affect fund inflows and outflows. Healthcare has defensive characteristics, but it is worth bearing in mind that regional risk tied to China also comes into play.
KraneShares MSCI All China Healthcare ETF Pros and Cons
Its strength is easy access to the growth theme of Chinese healthcare, while regional and regulatory risk and volatility are its weaknesses.
💪 Key Strengths
⚠️ Points to Watch
KraneShares MSCI All China Healthcare ETF Alternative ETFs and Related Products
KWEB, CQQQ, and others shown in the table are alternative themes focused on Chinese internet and technology, while CHIQ and similar funds hold Chinese consumer stocks. Their sector character differs from healthcare, but to broaden exposure to the same Chinese market, you can also consider MCHI, which centers on large caps, FXI, which centers on blue chips, ASHR, which centers on mainland A-shares, and KBA, which holds mainland large caps.
Peer Comparison ETFs| Ticker | Name | Price | Change | AUM | Total Expense Ratio | Dividend Yield | 1Y |
|---|---|---|---|---|---|---|---|
 KWEB | KraneShares CSI China Internet ETF | $22.79 | -0.9% | $4.3B | 0.69% | 9.2% | -44.6% |
 CQQQ | Invesco China Technology ETF | $38.74 | -2.6% | $1.9B | 0.65% | 2.91% | -33.6% |
 EMQQ | EMQQ The Emerging Markets Internet ETF | $29.36 | +0.3% | $220.2M | 0.86% | 4.25% | -36.2% |
 INCO | Columbia India Consumer ETF | $58.06 | +1.3% | $202.2M | 0.75% | - | -11.8% |
 CHIQ | Global X MSCI China Consumer Discretionary ETF | $15.37 | -0.5% | $97.2M | 0.65% | 1.85% | -34.9% |
Top Holdings| Ticker | Name | Weight | Price | Change | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|---|
| ONC | BeOne Medicines Ltd ADR | 0.17% | $371.56 | -0.5% | $38.7B | 65.3 | - |
 IVZ | Invesco Ltd | 0.05% | $29.02 | +1.2% | $12.8B | - | 2.96% |
 LEGN | Legend Biotech Corp ADR | 0.02% | $22.30 | -1.0% | $4.3B | - | - |
KraneShares MSCI All China Healthcare ETF Investor Checkpoints
Here are the points to review before investing in KURE. Because it is a sector theme ETF, it is wise to carefully check China regional risk, volatility, and the long-term cost burden in advance.
| Checkpoint | What to check | Current status |
|---|---|---|
| 💵 Expense ratio | Check the effect of cumulative costs over a long holding period | Annual fee applies |
| 🌏 Regional risk | Review China's policy and regulatory environment | Needs review |
| 📊 Sector concentration | Check the degree of single-sector exposure | Concentrated in healthcare |
| 💱 Exchange rate | Impact on returns converted from yuan and dollars | No currency hedge |
China regional risk and concentrated sector exposure are the main drivers of volatility. Short-term losses can be significant if policy shifts or the external environment worsens, so position sizing within the portfolio is necessary.
This is a product worth considering for investors who want diversified exposure to the growth theme of Chinese healthcare. However, given the high regional risk and volatility, it is advisable to consider both a long-term perspective and weight management.
SubscribeDisclaimer: This content is for informational purposes only and does not constitute investment advice. All investment responsibility lies with the investor.
This article reflects information as of July 2, 2026.
Today's 5 AI picks, all free